NO995591D0 - Geler med forsinket, langvarig frigjörelse - Google Patents

Geler med forsinket, langvarig frigjörelse

Info

Publication number
NO995591D0
NO995591D0 NO995591A NO995591A NO995591D0 NO 995591 D0 NO995591 D0 NO 995591D0 NO 995591 A NO995591 A NO 995591A NO 995591 A NO995591 A NO 995591A NO 995591 D0 NO995591 D0 NO 995591D0
Authority
NO
Norway
Prior art keywords
gels
delayed
long
lasting release
lasting
Prior art date
Application number
NO995591A
Other languages
English (en)
Norwegian (no)
Other versions
NO995591L (no
Inventor
Merrill Seymour Goldenberg
Alice C Beekman
Jian Hua Gu
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of NO995591L publication Critical patent/NO995591L/no
Publication of NO995591D0 publication Critical patent/NO995591D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO995591A 1997-05-16 1999-11-15 Geler med forsinket, langvarig frigjörelse NO995591D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85797397A 1997-05-16 1997-05-16
US91290297A 1997-08-15 1997-08-15
PCT/US1998/010013 WO1998051348A2 (en) 1997-05-16 1998-05-18 Sustained-release delayed gels

Publications (2)

Publication Number Publication Date
NO995591L NO995591L (no) 1999-11-15
NO995591D0 true NO995591D0 (no) 1999-11-15

Family

ID=27127437

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995591A NO995591D0 (no) 1997-05-16 1999-11-15 Geler med forsinket, langvarig frigjörelse

Country Status (18)

Country Link
EP (1) EP0981374B1 (https=)
JP (1) JP2001525826A (https=)
KR (1) KR20010012374A (https=)
AU (1) AU7491898A (https=)
BG (1) BG64860B1 (https=)
BR (1) BR9809117A (https=)
CA (1) CA2289196C (https=)
CZ (1) CZ299180B6 (https=)
DE (1) DE69838750T2 (https=)
EA (1) EA199901013A1 (https=)
ES (1) ES2294814T3 (https=)
HU (1) HUP0003393A3 (https=)
IL (1) IL132814A0 (https=)
NO (1) NO995591D0 (https=)
PL (1) PL199565B1 (https=)
SK (1) SK286437B6 (https=)
WO (1) WO1998051348A2 (https=)
YU (1) YU58599A (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003200609B2 (en) * 1998-05-18 2006-02-23 Amgen Inc. Biodegradable sustained-release alginate gels
US6432449B1 (en) * 1998-05-18 2002-08-13 Amgen Inc. Biodegradable sustained-release alginate gels
JP2000256216A (ja) * 1999-03-04 2000-09-19 Meiji Milk Prod Co Ltd ゲル組成物
US7651703B2 (en) 1999-10-15 2010-01-26 Genentech, Inc. Injection vehicle for polymer-based formulations
US7582311B1 (en) 1999-10-15 2009-09-01 Genentech, Inc. Injection vehicle for polymer-based formulations
EP1233751A1 (en) * 1999-11-29 2002-08-28 ADVANCED RESEARCH AND TECHNOLOGY INSTITUTE, Inc. Sustained percutaneous delivery of a biologically active substance
FR2823119B1 (fr) * 2001-04-05 2004-02-20 Seppic Sa Adjuvant d'immunite contenant un cation metallique complexe et vaccin le contenant
CN1703198A (zh) * 2002-10-25 2005-11-30 辉瑞产品公司 呈混悬剂形式的芳基杂环活性物质的贮库制剂
CA2621365C (en) * 2005-05-23 2012-09-04 Natural Alternatives International Compositions and methods for the sustained release of beta-alanine
US20070202186A1 (en) 2006-02-22 2007-08-30 Iscience Interventional Corporation Apparatus and formulations for suprachoroidal drug delivery
JP5107585B2 (ja) * 2007-01-29 2012-12-26 株式会社 メドレックス 低温充填ゼリー組成物とその製造方法
EP1985286A1 (en) * 2007-04-24 2008-10-29 Biocompatibles UK Limited Microspheres for treatment of brain tumours
JP5996544B2 (ja) 2010-10-15 2016-09-21 クリアサイド・バイオメディカル・インコーポレーテッドＣｌｅａｒｓｉｄｅ Ｂｉｏｍｅｄｉｃａｌ Ｉｎｃｏｒｐｏｒａｔｅｄ 眼球アクセス用装置
MX373894B (es) 2012-11-08 2020-07-09 Clearside Biomedical Inc Métodos y dispositivos para el tratamiento de trastornos oculares en sujetos humanos.
BR112015027762A2 (pt) 2013-05-03 2017-08-29 Clearside Biomedical Inc Aparelho e métodos para injeção ocular
US10010447B2 (en) 2013-12-18 2018-07-03 Novartis Ag Systems and methods for subretinal delivery of therapeutic agents
EP3157598A4 (en) 2014-06-20 2018-05-16 Clearside Biomedical, Inc. Variable diameter cannula and methods for controlling insertion depth for medicament delivery
US10390901B2 (en) 2016-02-10 2019-08-27 Clearside Biomedical, Inc. Ocular injection kit, packaging, and methods of use
EP3452165A1 (en) 2016-05-02 2019-03-13 Clearside Biomedical, Inc. Systems and methods for ocular drug delivery
IL305537B2 (en) 2016-08-12 2025-02-01 Clearside Biomedical Inc Devices and methods for adjusting the insertion depth of a needle for administering a drug
US12090294B2 (en) 2017-05-02 2024-09-17 Georgia Tech Research Corporation Targeted drug delivery methods using a microneedle
CN112367841B (zh) * 2018-06-04 2023-06-09 斯博姆维透公司 用于制备水凝胶的功能化试剂盒
US20210369875A1 (en) * 2018-11-06 2021-12-02 National Cancer Center Alginic acid-based injectable hydrogel system
WO2021067076A1 (en) * 2019-10-01 2021-04-08 Brillian Pharma Inc. Methods for treating or preventing obesity and body weight management
WO2021193981A1 (ja) * 2020-03-26 2021-09-30 国立大学法人大阪大学 三次元（３ｄ）組織培養用のサポーティングバス
CN114533653B (zh) * 2020-11-26 2023-12-22 上海凯茂生物医药有限公司 一种人促红素杂合Fc融合蛋白相变型制剂及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5416979B2 (https=) * 1972-01-08 1979-06-26
US4241099A (en) * 1979-02-26 1980-12-23 Tiemstra Peter J Pectin formulations, products and methods having delayed-action acidulants
US4690682A (en) * 1983-04-15 1987-09-01 Damon Biotech, Inc. Sustained release
US4789516A (en) * 1983-04-15 1988-12-06 Damon Biotech, Inc Production of sustained released system
US4744933A (en) * 1984-02-15 1988-05-17 Massachusetts Institute Of Technology Process for encapsulation and encapsulated active material system
CA1215922A (en) * 1984-05-25 1986-12-30 Connaught Laboratories Limited Microencapsulation of living tissue and cells
JPS645460A (en) * 1987-06-29 1989-01-10 Sanei Kagaku Kogyo Kk Production of delaying gelatinous material
JPH0794583B2 (ja) * 1989-12-15 1995-10-11 株式会社大塚製薬工場 高含水高分子ゲル
IT1245383B (it) * 1991-03-28 1994-09-20 Eniricerche Spa Composizione acquosa gelificabile avente tempo di gelificazione ritardato
US5711968A (en) * 1994-07-25 1998-01-27 Alkermes Controlled Therapeutics, Inc. Composition and method for the controlled release of metal cation-stabilized interferon
KR960006730B1 (ko) * 1993-02-11 1996-05-23 재단법인한국화학연구소 에멀젼 네트웍(emulsion network)을 이용한 약물의 피부 전달체계
GB9708773D0 (en) * 1997-04-30 1997-06-25 Reckitt & Colmann Prod Ltd Organic compositions

Also Published As

Publication number Publication date
NO995591L (no) 1999-11-15
CA2289196C (en) 2007-08-07
JP2001525826A (ja) 2001-12-11
CZ396399A3 (cs) 2000-04-12
DE69838750D1 (de) 2008-01-03
IL132814A0 (en) 2001-03-19
HUP0003393A3 (en) 2001-03-28
BR9809117A (pt) 2000-08-01
WO1998051348A3 (en) 1999-02-18
EA199901013A1 (ru) 2000-06-26
BG103914A (en) 2000-07-31
DE69838750T2 (de) 2008-10-30
YU58599A (sh) 2000-12-28
ES2294814T3 (es) 2008-04-01
BG64860B1 (bg) 2006-07-31
SK286437B6 (sk) 2008-10-07
SK154399A3 (en) 2000-07-11
HUP0003393A2 (hu) 2001-02-28
EP0981374B1 (en) 2007-11-21
PL199565B1 (pl) 2008-10-31
KR20010012374A (ko) 2001-02-15
PL336887A1 (en) 2000-07-17
EP0981374A2 (en) 2000-03-01
AU7491898A (en) 1998-12-08
CZ299180B6 (cs) 2008-05-14
WO1998051348A2 (en) 1998-11-19
CA2289196A1 (en) 1998-11-19

Similar Documents

Publication Publication Date Title
NO995591D0 (no) Geler med forsinket, langvarig frigjörelse
NO20012139D0 (no) Multipartikkelformig sammensetning med modifisert frigjöring
DE69818711D1 (de) Schutzhelmsystem
ID28990A (id) Herbisida-herbisida dengan urea aminofenilsulfonil asilasi
DE69908491D1 (de) Integralhelm
DE69934755D1 (de) Integralhelm
DE69914279D1 (de) Klammer
NO20010873L (no) Mikropartikkel-blanding
DE60014260D1 (de) Klammer
NO991372D0 (no) Trinn med reflektorer
FI980856A0 (fi) Andningsskydd utrustad med en identifierare
DK0991353T3 (da) Klemindretning
IT1292278B1 (it) Termodepuratore
DE69838302D1 (de) Gruppenlaufzeitentzerrer
DE69907428D1 (de) Katalysatorzusammensetzung
DE19848663B4 (de) Schutzhelm
DE59804378D1 (de) Schutzhelm
KR980000315U (ko) 다용도 클립
DE60012109D1 (de) Klammer
ATA37499A (de) Klammer
ES1039737Y (es) Acumulador termico perfeccionado.
ITRM980205A0 (it) Fermaglio serra- cravatta
FI982820A0 (fi) Kypärä
SE9800559D0 (sv) Hjälm
FIU980400U0 (fi) Savupiipun sadehattu

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application